Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 21, 2020
Cipher announced the Company received a Notice of Termination from Bausch Health in connection with the License, Development and Commercialization Agreement of Trulance.
read more
Wednesday, January 22, 2020
Civica Rx has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway.
read more
Thursday, January 23, 2020
Catalent supports the news that DiaMedica received FDA approval to commence Phase 2 clinical trials of DM199 for chronic kidney disease.
read more
Thursday, January 23, 2020
Genome & Company has entered into a clinical trial collaboration and supply agreement with Merck KGaA and Pfizer to evaluate GEN-001 therapy in combination with avelumab.
read more
Tuesday, January 28, 2020
CNS announced Anthem Biosciences of Bangalore, India has completed a pilot run of the recrystallization of the Reata Pharmaceuticals API.
read more
Tuesday, January 28, 2020
PharmaMar and Bionical Emas have announced the launch of an EAP for lurbinectedin to treat patients in the United States with relapsed SCLC, who are unable to enter clinical trials and there are no appropriate alternative treatments.
read more
Wednesday, January 29, 2020
GeoVax Labs and BravoVax announced the signing of a Letter of Intent to jointly develop a vaccine against the new coronavirus (known as 2019-nCoV).
read more
Tuesday, February 04, 2020
The FDA has posted laboratory results showing N- Nitrosodimethylamine (NDMA) levels in some metformin products approved in the U.S.
read more
Wednesday, February 05, 2020
CURE Pharmaceutical has signed an exclusive licensing agreement with ReLeaf Europe, one of Europe’s pharmaceutical groups specialized in medicinal cannabis products.
read more
Wednesday, February 19, 2020
The FDA plays an essential role in overseeing our Nation’s medical products as part of our vital mission to protect and promote public health, including during public health emergencies.
read more
Wednesday, February 19, 2020
Dr. Reddy’s Laboratories has entered into a definitive agreement with Wockhardt Limited to acquire select divisions of its branded generics business.
read more
Thursday, February 20, 2020
Hummingbird Bioscience has signed an agreement with Mycenax Biotech for the production of material for the Phase 1 clinical trial of its HMBD-002 program.
read more
Friday, February 21, 2020
Sihuan announced Xuanzhu Biopharmaceutical acquired all interests and intellectual property rights of plazomicin.
read more
Monday, February 24, 2020
Taro is voluntarily recalling two lots of Phenytoin Oral Suspension USP, 125 mg/5 mL both in 237 mL bottles, to the consumer level.
read more
Monday, February 24, 2020
Dipharma Francis announced the completion of the new cGMP Quality Control laboratory and c-GMP kilolab at its CDMO site located in Kalamazoo MI.
read more